Reducing Alcohol Involved Sexual Violence in Higher Education
Launched by UNIVERSITY OF PITTSBURGH · Dec 22, 2021
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Reducing Alcohol Involved Sexual Violence in Higher Education" (RAISE), aims to address two big issues on college campuses: alcohol-related sexual violence and heavy drinking among students. The study is looking at undergraduate students, especially those at higher risk, such as those with a history of sexual violence, those who identify as sexual or gender minorities, and students with disabilities. Researchers will test new strategies to improve support services at college health and counseling centers and provide tools to help students make safer choices regarding alcohol use and sexual consent.
To participate in this study, you need to be an undergraduate student aged 18 to 24 who is seeking care at one of the participating college health or counseling centers. If you join, you can expect to engage in various activities aimed at preventing alcohol-related sexual violence and enhancing your access to confidential support services. This trial represents an important step in creating safer college environments by tackling these critical public health issues directly where students seek help.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • undergraduate student enrolled at participating college campus
- • age 18-24 years
- • seeking care at a participating campus college health or counseling center for any reason
- Exclusion Criteria:
- • under the age of 18
- • not enrolled as an undergraduate at a participating campus
- • not seeking care at college health or counseling center
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials